BridgeMD
New treatment option for Carpal Tunnel Syndrome
Official title Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block
ClinicalTrials.gov ID: NCT05372393
What this study is testing
- What it's testing
- Carpal tunnel syndrome (CTS) is the most commonly appearing entrapment neuropathy of the upper extremity. Treatment options include both non-operative and operative methods.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ≥18 years of age
- CTS verified by nerve conduction studies
- Symptoms suitable for CTS
You likely can't join if
- Recurrent CTS
- Peripheral neuropathies
- Known allergy to the trial drugs
- Profound cognitive impairment
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Kuopio, Northern Savonia, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kuopio, Northern Savonia, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.